Etoposide combined with ruxolitinib for refractory hemophagocytic lymphohistiocytosis during pregnancy: a case report and literature review.

In conclusion, this study highlights the challenges and difficulties in the diagnosis and management of patients with HLH during pregnancy. Moreover, this is the first case report of etoposide combined with ruxolitinib in the treatment of patients with refractory secondary HLH during pregnancy. PMID: 33138732 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33138732?dopt=Abstract

Source: Hematology - November 5, 2020 Category: Hematology Tags: Hematology Source Type: research